Home›Stock Screener›Vaishali Pharma›Financial Statements

Vaishali Pharma Financial Statements

12 Years of Data
2026 - 2015

Vaishali Pharma financial statements. In FY2026, Vaishali Pharma (VAISHALI) reported revenue ₹31 Cr, net profit ₹2 Cr and EPS ₹0.16, with a net profit margin of 6.5% and ROE of 2.9%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore VAISHALI investment value to estimate fundamental worth using multiple valuation models.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 6.45% 2026 data
EBITDA Margin 9.68% 2026 data
Operating Margin 7.00% 2026 data
Return on Assets 1.63% 2026 data
Return on Equity 2.90% 2026 data

Balance Sheet Ratios

Equity Ratio 56.10% 2026 data
Asset Turnover 0.25 2026 data

VAISHALI Revenue, Net Profit & EBITDA — Year-on-Year Growth

VAISHALI YoY (Sept 2025 vs Sept 2026) — revenue -8.8%, net profit +100.0%, EBITDA +50.0%, expenses -12.5%. See VAISHALI book value to compare market price against book value per share.

Revenue Growth
-8.8%
Year-over-Year
Net Profit Growth
+100.0%
Year-over-Year
EBITDA Growth
+50.0%
Year-over-Year
Expense Growth
-12.5%
Year-over-Year
Assets Growth
+11.8%
Year-over-Year
Equity Growth
+6.2%
Year-over-Year
Operating Cash Flow Growth
+100.0%
Year-over-Year
Financing Cash Flow Growth
-73.7%
Year-over-Year

VAISHALI Income Statement — Revenue, EBITDA & Net Profit

Vaishali Pharma revenue ₹31 Cr, EBITDA ₹3 Cr, net profit ₹2 Cr, EPS ₹0.16 (2026) — net profit margin 6.5%. For live price, earnings ratios and company overview, see Vaishali Pharma screener.

Periods ₹ Crores
Particulars Sept 2026 Mar 2026 Jun 2026 Sept 2025 Jun 2025 Dec 2025
Revenue 31 28 24 34 25 26
Expenses 28 27 21 32 22 23
EBITDA 3 1 2 2 2 2
Operating Profit Margin % 7.00% -1.00% 6.00% 4.00% 6.00% 6.00%
Depreciation 0 0 0 0 0 0
Interest 0 1 0 0 0 1
Profit Before Tax 3 0 2 2 2 2
Tax 0 0 0 1 1 1
Net Profit 2 0 2 1 1 1
Earnings Per Share (₹) 0.16 0.03 0.12 0.09 0.10 0.10

VAISHALI Balance Sheet — Assets, Liabilities & Shareholders' Equity

VAISHALI total assets ₹123 Cr, total equity ₹69 Cr, total liabilities ₹ Cr (2026) — ROE 2.9%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017
ASSETS
Total Assets 123 110 80 79 82 86 66 69 64 45
Current Assets
Fixed Assets 2 2 2 2 1 1 2 1 1 1
Capital Work in Progress 0 0 1 1 1 0 0 0 0 0
Investments 5 0 0 0 0 0 0 0 0 0
Other Assets 116 107 77 76 80 84 64 67 62 43
LIABILITIES
Total Liabilities
Current Liabilities 6 5 4 6 3 4 4 5 3 4
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 69 65 43 41 26 22 21 21 21 4
Share Capital 26 26 11 11 11 11 11 7 7 3
Reserves & Surplus 43 39 32 30 16 12 11 15 14 1

VAISHALI Cash Flow Statement — Operating, Investing & Financing

Vaishali Pharma operating cash flow ₹0 Cr, investing ₹-5 Cr, financing ₹5 Cr, net cash flow ₹0 Cr (2026).

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 0 -18 1 1 1 2 3 4 -10 1 5 -4
Investing Activities -5 0 1 0 -1 0 0 0 1 1 3 2
Financing Activities 5 19 -1 -2 0 -2 -3 -4 9 -1 -8 2
Net Cash Flow 0 0 1 0 1 0 0 0 0 0 0 0